WI Harper Group

03/11/2026

💡 As a continuation of the 2025 Taiwan Startup Ecosystem Report by the Taiwan Institute of Economic Research (TIER) & PwC, our Senior Partner at WI Harper Group, Sean Peng, recently shared his perspective as a seasoned venture capitalist!

Sean discusses how Taiwanese startups can truly stand out by seizing AI opportunities. His main takeaway? Real competitive advantage comes from:
🌍 Stepping out into overseas markets firsthand
🤝 Establishing authentic global connections
⚙️ Building agile, cross-functional teams

Check out the full article to learn how startups and investors can partner up to anticipate risks and tackle global challenges together! 🚀👇

🔗 https://www.digitimes.com.tw/tech/dt/n/shwnws.asp?CnlID=13&id=747278

創業是一場關於實力、韌性與視野的漫長馬拉松，沿途挑戰不斷，卻沒有真正的終點。深耕創投界30餘年的美商中經合集團資深合夥人彭適辰，接觸過無數新創團隊，從他的投資視角出發，淬煉出對台灣新創的深刻洞察與建言。

11/20/2025

WI Harper–backed portfolio company 🎉 Health2Sync has officially launched on the Emerging Stock Board (7851-TW)

We have been cheering for them since their early Series A days and it is inspiring to see the momentum they have built.

Health2Sync has spent years reshaping the future of health tech and chronic disease management. Their flagship app now supports more than 1.6 million users and their cloud care platforms and DTx solutions are driving meaningful change across the industry.

This milestone opens an exciting new chapter for the team. Congratulations to everyone at Health2Sync and here is to even greater breakthroughs ahead!

https://www.businesstoday.com.tw/article/category/183015/post/202511120022/

08/20/2025

🚀 WI Harper Leads AIM’s NT$125M Pre-A Round – Transforming AI Healthcare Across Asia! 🌏

Co-led by BE Health, with participation from Cathay Venture and SIC (Sustainable Impact Capital), this round drives AI healthcare innovation across Asia and beyond.
💡 Funding Highlights:
• Support AI imaging products: DeepXray & DeepSono
• Global regulatory approvals ✅
• International patent deployment ✅
• Market expansion: U.S., Japan, Southeast Asia ✅

🌍 Global Vision:
AIM leverages cutting-edge AI technology and international partnerships to enhance medical imaging solutions and patient care, moving toward becoming a leading smart healthcare brand in the Asia-Pacific region.

📖 Read more:

中經合資深合夥人彭適辰表示，此次不僅是投入資金並參與董事會運作，協助公司制定國際市場策略、引介海外資源與國際資金，並導入公司治理經驗，全方位推動國際化與商業化進程。作為全球跨境創投先驅，美商中經合集團...

02/18/2025

WI Harper Group is thrilled to support Phase in their $13M funding round as they take their no-code UI/UX design platform to the next level! . Phase is revolutionizing the way designers turn their visions into reality—eliminating manual coding and optimizing workflows to enhance productivity. With this new funding, Phase is poised to expand its market presence and unveil innovative tools that simplify UI/UX design processes even further. Congratulations to Nick Budden and the entire Phase team on this remarkable achievement! 👏👏👏

UX and UI designers work closely with engineers throughout product development to build and implement design concepts and wireframes for functional user

02/06/2025

WI Harper-backed Kdan has officially commenced trading on the Emerging Stock Board (ESB) as of February 5, 2025! This marks a proud milestone for WI Harper as we witness Kdan’s step up into the capital market. As a standout company from our FUND VIII portfolio, Kdan is a Taiwan-born innovator making a global impact with its AI-driven workflow and data solutions. Congratulations to Kdan on this remarkable achievement! 👏 👏 👏 👏 👏

https://lnkd.in/gam9FuZu

05/03/2024

"Meet invites Sean, Senior Partner of WI Harper Group, to their podcast to chat about the mindset of entrepreneurship/investment and perspectives on market trends! Check it out! (Note: The podcast is conducted in Mandarin.) [Link: https://reurl.cc/YEXNkL]"

06/22/2021

A significant step for drug discovery! Circle Pharma

WI Harper Group | June 21, 2021 | Source: Business wire Circle Pharma, a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 million in an oversubscribed Series C financing. The financing was co-led by The Column Group and Nextech...

06/08/2021

WI Harper Group-backed RWDC Partners with Kimberly-Clark to Design Sustainable Alternatives to Traditional Plastics

WI Harper Group | June 8, 2021 | Source: PR Newswire In pursuit of its 2030 ambition to reduce the use of fossil fuel-based plastics by half before the end of the decade, Kimberly-Clark announced a partnership with WI Harper-backed biotech company RWDC Industries to advance sustainable technology fo...

06/02/2021

WI Harper-backed Engine Biosciences raises $57M in oversubscribed Series A led by US-based Polaris Partners

WI Harper Group | June 2, 2021 | Source: The Business Times ENGINE Biosciences, a biotech company that applies machine learning as well as large-scale biology testing to discover precision medicine-based therapies for cancer and other diseases, has raised $57 million in an oversubscribed Series A fu...

05/13/2021

We are a global community, global family. Both WI Harper and Daokang will continue to pay attention, monitor and support India on overcoming the pandemic together.

WI Harper Group | May 12, 2021 During the past few weeks the Covid-19 crisis has become critical in India with cases sharply rising across the country. In efforts to help, Daokang, WI Harper backed insurtech company based in Beijing, has sent oxygen machines and other necessary equipments to their I...

04/07/2021

WIH Alert 【中经合声明】

03/30/2021

WI Harper Group backed Appier goes public on Tokyo Stock Exchange!

WI Harper Group | March 30, 2020 On March 30, 2021, Appier successfully listed on the Mothers Board, Tokyo Stock Exchange in Japan (Stock code: 4180). Appier is not only recognized as one of Taiwan first unicorns but also the first company to list in Japan since Trend Micro in 1998. WI Harper Group....